Phosphofructokinase deficiency is a rare disorder with less than 100 reported cases; the contribution of altered glucose metabolism in other tissues to the pathogenesis of the disease is not fully understood. The authors present a unique case of portal and mesenteric vein thrombosis in a 43-year-old man with a known case of phosphofructokinase deficiency.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MAJ.0b013e31820e7eee | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Small Leucine Zipper Protein Regulates Glucose Metabolism of Prostate Cancer Cells via Induction of Phosphoglycerate Kinase 1.
Cancers (Basel)
November 2024
Division of Life Sciences, Korea University, Seoul 02841, Republic of Korea.
Article Synopsis
- Cancer cells alter their metabolism by using glucose to produce lactate, leading to an acidic environment that supports tumor growth; this study focuses on how the protein sLZIP affects this process in prostate cancer.* -
- Depleting sLZIP reduces the expression of key glycolytic genes, particularly PGK1, which negatively impacts the cancer cells' ability to perform glycolysis and affects their growth and energy production.* -
- The research shows that sLZIP is crucial for prostate cancer metabolism, as its absence reduces tumor growth and lactate production, while reintroducing PGK1 can restore aerobic glycolysis in these cells.*
A comprehensive analysis of the defense responses of Odontotermes formosanus (Shiraki) provides insights into the changes during Serratia marcescens infection.
BMC Genomics
November 2024
Co-Innovation Center for Sustainable Forestry in Southern China, Nanjing Forestry University, Nanjing, 210037, China.
Background: Odontotermes formosanus (Shiraki) is a highly damaging agroforestry pest. Serratia marcescens is a broad-spectrum insecticidal pathogen and is highly lethal to O. formosanus.
View Article and Find Full Text PDFProtein kinase N1 deficiency results in upregulation of cerebral energy metabolism and is highly protective in in vivo and in vitro stroke models.
Metabolism
December 2024
Medical University of Innsbruck, CCB-Biocenter, Institute of Neurobiochemistry, Innrain 80-82, A-6020 Innsbruck, Austria.
Background And Aim: We recently identified protein kinase N1 (PKN1) as a master regulator of brain development. However, its function in the adult brain has not been clearly established. In this study, we assessed the cerebral energetic phenotype of wildtype (WT) and global Pkn1 knockout (Pkn1) animals under physiological and pathophysiological conditions.
View Article and Find Full Text PDFTrim21 mediates metabolic reprogramming in renal tubular cells via PFKP ubiquitination to alleviate renal fibrosis.
J Cell Physiol
December 2024
Department of Nephrology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chronic kidney disease (CKD), stemming from varied nephric impairments, manifests a steadily escalating global incidence. As a progressive pathological condition, CKD is typified by an intensification in the gravity of renal interstitium fibrotic transformations. Nonetheless, the intrinsic mechanisms underpinning nephric fibrosis remain elusive.
View Article and Find Full Text PDFA comprehensive prognostic and immunological implications of PFKP in pan-cancer.
Cancer Cell Int
September 2024
Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjiang, 150040, China.
Background: Phosphofructokinase P (PFKP) is a key rate-limiting enzyme in glycolysis, playing a crucial role in various pathophysiological processes. However, its specific function in tumors remains unclear. This study aims to evaluate the expression and specific role of PFKP across multiple tumor types (Pan-cancer) and to explore its potential clinical significance as a therapeutic target in cancer treatment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!